Abstract
Medication overuse headache (MOH) leads to high disability and poor quality of life; the debate on value and method of detoxification is still open, even more at the present time with new preventive treatments available. The aim of this study is to estimate the effectiveness of detoxification in multi-resistant chronic migraine (CM) with MOH patients who start prophylaxes Anti-CGRP monoclonal antibodies (mAb).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
